HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cysteinyl leukotriene-dependent interleukin-5 production leading to eosinophilia during late asthmatic response in guinea-pigs.

AbstractBACKGROUND:
Allergic airway eosinophilia is suppressed by cysteinyl leukotriene (CysLT) receptor (CysLT1 receptor) antagonists in several species including humans and guinea-pigs, suggesting that CysLTs are directly or indirectly involved in induction of the response.
OBJECTIVE:
We examined the effect of CysLT antagonists (pranlukast and MCI-826) on antigen inhalation-induced eosinophilia in peripheral blood and lung, and on IL-5 activity in serum during late increase of airway resistance (late asthmatic response, LAR) in sensitized guinea-pigs.
METHODS:
Guinea-pigs inhaled ovalbumin (OVA) + Al(OH)3 and OVA mists alternately for sensitization and challenge, respectively, once every 2 weeks. At the fifth challenge, the effects of CysLT antagonists and an anti-IL-5 antibody (TRFK-5) on the occurrence of LAR, and blood and lung eosinophilia, which appeared at 5 h after challenge, were examined. The time-course of IL-5 activity in the serum after the challenge was evaluated by measuring in vitro 'eosinophil survival prolongation activity'. The influence of CysLT antagonists on IL-5 activity was assessed.
RESULTS:
CysLT antagonists and TRFK-5 completely abolished blood and lung eosinophilia. LAR was suppressed by both MCI-826 and TRFK-5 by 40-50%. Sera obtained from sensitized, challenged animals 3 h and 4 h after challenge induced an obvious prolongation of eosinophil survival. The activity of the sera was completely neutralized by prior exposure to TRFK-5, suggesting that it reflected IL-5 activity. Increased IL-5 activity in the serum was inhibited by both pranlukast and MCI-826 by over 90%.
CONCLUSIONS:
CysLTs produced after antigen provocation sequentially induced IL-5 production from some immune component cells via CysLT1 receptor activation. Thus, it is likely that CysLTs indirectly cause antigen-induced eosinophilia through IL-5 production.
AuthorsT Nabe, K Yamashita, M Miura, T Kawai, S Kohno
JournalClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (Clin Exp Allergy) Vol. 32 Issue 4 Pg. 633-40 (Apr 2002) ISSN: 0954-7894 [Print] England
PMID11972613 (Publication Type: Journal Article)
Chemical References
  • Chromones
  • Interleukin-5
  • Leukotriene Antagonists
  • Leukotrienes
  • Membrane Proteins
  • Receptors, Leukotriene
  • Thiazoles
  • cysteinyl-leukotriene
  • MCI 826
  • Ovalbumin
  • cysteinyl leukotriene receptor 2
  • Cysteine
  • leukotriene D4 receptor
  • pranlukast
Topics
  • Animals
  • Asthma (immunology)
  • Cell Survival (drug effects)
  • Chromones (pharmacology)
  • Cysteine (physiology)
  • Eosinophilia (blood)
  • Guinea Pigs
  • Interleukin-5 (antagonists & inhibitors, biosynthesis, physiology)
  • Kinetics
  • Leukotriene Antagonists (pharmacology)
  • Leukotrienes (physiology)
  • Male
  • Membrane Proteins
  • Ovalbumin (immunology)
  • Pulmonary Eosinophilia (immunology)
  • Receptors, Leukotriene
  • Thiazoles (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: